[Osteoporosis pain management].
Osteoporosis is a chronic disease with an enormous impact on health care costs. Approximately 8 Mio. people are affected in Germany. A reasonable part of them is suffering from acute and/or chronic pain due to osteoporotic bone fractures and musculoskeletal malfunctioning. Therefore, pain therapy is based on the principles of acute pain treatment and chronic pain therapy.Drug effects and side effects have to be considered with respect to fracture healing, bone mineral density and fracture risk.
Dinges
Gerhard
G
Oberarzt an der Klinik für Anästhesie und Intensivtherapie und geschäftsführender Arztlicher Leiter des interdisziplinären Zentrums für Schmerztherapie, Universitätsklinikum Giessen und Marburg GmbH, Standort Marburg. Gerhard.Dinges@med.uni-marburg.de
D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002908:Chronic Disease; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D010024:Osteoporosis / Q000150:complications* / Q000175:diagnosis; D010146:Pain / Q000175:diagnosis / Q000209:etiology*; D059408:Pain Management; D018570:Risk Assessment
D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors